Skip to search formSkip to main contentSkip to account menu

Wy 42362

Known as: Wy-42,362, Wy-42362 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

recainam

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1988
1988
Effect of recainam on the energy required for ventricular defibrillation in dogs as assessed with implanted electrodes.
1988
1988
Cardiac electrophysiology of the antiarrhythmic agent recainam (Wy-42,362) in anesthetized dogs: relation to plasma and myocardial concentrations.
: The present study was undertaken to characterize the cardiac electrophysiologic effects of the investigational class I… 
1988
1988
Cardiac Electrophysiology of the Antiarrhythmic Agent Recainam (Wy‐42,362) in Anesthetized Dogs: Relation to Plasma and Myocardial Concentrations
The present study was undertaken to characterize the cardiac electrophysiologic effects of the investigational class. I… 
1983
1983
Antiarrhythmic, hemodynamic and cardiac electrophysiological evaluation of N-(2,6-dimethylphenyl)-N'-[3-(1-methylethylamino)propyl]urea (Wy-42,362).
The antiarrhythmic, hemodynamic and cardiac electrophysiological effects of (Wy-42,362, in the following briefly called Wy) N-(2… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)